NanoVibronix, Inc.

NasdaqCM:NAOV Stock Report

Market Cap: US$2.0m

NanoVibronix Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Brian Murphy

Chief executive officer

US$542.1k

Total compensation

CEO salary percentage55.3%
CEO tenure8.3yrs
CEO ownershipn/a
Management average tenure8.3yrs
Board average tenure9yrs

Recent management updates

Most Shareholders Will Probably Find That The Compensation For NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Is Reasonable

Dec 09
Most Shareholders Will Probably Find That The Compensation For NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Is Reasonable

Recent updates

Most Shareholders Will Probably Find That The Compensation For NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Is Reasonable

Dec 09
Most Shareholders Will Probably Find That The Compensation For NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Is Reasonable

NanoVibronix receives extension to satisfy Nasdaq bid price requirement

Oct 19

NanoVibronix rises 27% on approval of Uroshield for sale in UK by NHS internal supply chain contract

Sep 23

Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?

Jul 08
Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?

Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?

Mar 22
Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?

Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans?

Dec 01
Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans?

NanoVibronix: Portable Ultrasonic Therapeutic Devices

Sep 01

NanoVibronix (NASDAQ:NAOV) Is In A Good Position To Deliver On Growth Plans

Aug 17
NanoVibronix (NASDAQ:NAOV) Is In A Good Position To Deliver On Growth Plans

NanoVibronix announces expansion of distribution pact for its ultrasound devices

Dec 11

NanoVibronix secures $6M in equity capital

Dec 02

NanoVibronix reports Q3 results

Nov 17

CEO Compensation Analysis

How has Brian Murphy's remuneration changed compared to NanoVibronix's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$3m

Jun 30 2024n/an/a

-US$3m

Mar 31 2024n/an/a

-US$3m

Dec 31 2023US$542kUS$300k

-US$4m

Sep 30 2023n/an/a

-US$5m

Jun 30 2023n/an/a

-US$5m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022US$409kUS$300k

-US$5m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021US$407kUS$231k

-US$14m

Sep 30 2021n/an/a

-US$13m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$8m

Dec 31 2020US$365kUS$231k

-US$4m

Sep 30 2020n/an/a

-US$5m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$4m

Dec 31 2019US$512kUS$231k

-US$6m

Sep 30 2019n/an/a

-US$6m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$591kUS$231k

-US$4m

Compensation vs Market: Brian's total compensation ($USD542.13K) is about average for companies of similar size in the US market ($USD645.47K).

Compensation vs Earnings: Brian's compensation has increased whilst the company is unprofitable.

CEO

Brian Murphy (67 yo)

8.3yrs

Tenure

US$542,131

Compensation

Mr. Brian M. Murphy has been the Chief Executive Officer of NanoVibronix Inc. since October 13, 2016. Mr. Murphy has sales, operations and general management experience in medical devices and medical techn...

Leadership Team

NamePositionTenureCompensationOwnership
Brian Murphy
CEO & Director8.3yrsUS$542.13kno data
Stephen Brown
Chief Financial Officer4.3yrsUS$361.67k0.0053%
$ 109.1
Harold Jacob
Chief Medical Officer & Director10.8yrsUS$16.54k0.016%
$ 337.1
Amir Rippel
Vice President of Marketingno datano datano data
Lindsey Harrison
Vice President of Salesno datano datano data

8.3yrs

Average Tenure

68yo

Average Age

Experienced Management: NAOV's management team is seasoned and experienced (8.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Brian Murphy
CEO & Director8.3yrsUS$542.13kno data
Harold Jacob
Chief Medical Officer & Director21.3yrsUS$16.54k0.016%
$ 337.1
Shalom Hirschman
Member of Medical Advisory Boardno datano datano data
Thomas Mika
Independent Director9.8yrsUS$18.70k0%
$ 0
Christopher Fashek
Independent Chairman of the Board8.3yrsUS$180.52k0.10%
$ 2.0k
Dennis Maki
Member of Medical Advisory Boardno datano datano data
Phillip Hanno
Member of Medical Advisory Boardno datano datano data
Samuel Pinchas
Member of Medical Advisory Boardno datano datano data
Yechezkiel Caine
Member of Medical Advisory Boardno datano datano data
Mitchell Schwaber
Member of Medical Advisory Boardno datano datano data
Aurora Cassirer
Independent Director3yrsUS$16.79k0.0027%
$ 54.4
Michael Ferguson
Independent Director9.8yrsUS$18.23k0%
$ 0

9.0yrs

Average Tenure

71yo

Average Age

Experienced Board: NAOV's board of directors are considered experienced (9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 10:22
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NanoVibronix, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanDawson James Securities
Joseph GomesWm Smith & Co.
Brian MarckxZacks Investment Research Inc.